Bioceres, an Argentinian developer of crop productivity traits for genetically modified seeds, filed on Thursday with the SEC to raise up to $81 million in an initial public offering.
Bioceres has partnered with Arcadia Biosciences (RKDA), Dow (NYSE: DOW) and Verdeca to develop a soybean that demonstrates high tolerance to drought and salinity.
The Rosario, Argentina-based company, which was founded in 2002 and booked $11 million in sales for the 12 months ended June 30, 2015, plans to list on the NYSE under the symbol BIOX. Bioceres initially filed confidentially on May 20, 2015. Piper Jaffray and Itau BBA are the joint bookrunners on the deal. No pricing terms were disclosed.
